| Serial Number | 79305894 |
| Word Mark | BELMONITOR COV-2 |
| Filing Date | Tuesday, December 22, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 24, 2022 |
| Registration Number | 6720755 |
| Registration Date | Tuesday, May 24, 2022 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, February 22, 2022 |
| Description of Mark | The mark consists of the wording "BelMonitor" in stylized letter with "BEL" in dark blue and "MONITOR" in light blue with "COV-2" in white letters inside a light blue rectangle beneath the letters "BEL". |
| Goods and Services | Reagents for medical use; diagnostic chemical reagents for medical use; clinical medical reagents; clinical diagnostic reagents for medical purposes; enzymes for medical purposes with all of the foregoing for use in testing and diagnosing Sars-Cov-2 exposure; medical preparations and chemicals for pharmaceutical use, namely, for use in the treatment and disagnosis of SARS,COV-2 or Covid-19; pharmaceutical preparations in strip form for the treatment of Covid-19; pharmaceutical preparations for the prevention of disorders of the endocrine system that may be affected by Covid-19; chemical preparations for testing blood for medical purposes to determine Sars-Cov-2 or Covid-19 exposure; chemical preparations for medical purposes, namely, for the treatment of Covid-19; chemico-pharmaceutical preparations for the treatment of Covid-19; pharmaceutical preparations for the prevention of diseases of the metabolic system, in particular, Sars-Cov-2; in-vitro reagents for medical diagnostic purposes to determine exposure to Sars-Cov-2; chemical preparations for pharmaceutical purposes, namely, for treatment of Covid-19; medical diagnostic test strips for testing for Covid-19 viral infection; diagnostic agents for medical use and diagnostic reagents for medical use in testing for Sars-Cov-2 exposure; medicated mouth spray for treating Covid-19 viral infections; pharmaceutical preparations for the prevention of disorders of the metabolic system related to Sars-Cov-2 exposure; pharmaceutical preparations for the treatment of Covid-19 viral infections; chemical preparations for use in DNA analysis for medical purposes related to diagnosing and treating Sars-Cov-2; biological reagents for medical diagnostic use for medical purposes related to diagnosing and treating Sars-Cov-2; diagnostic chemical reagents for medical use related to diagnosing and treating Sars-Cov-2 |
| Pseudo Mark | BELMONITOR COV-TWO |
| Indication of Colors claimed | The color(s) light blue, dark blue and white is/are claimed as a feature of the mark. |
| Goods and Services | Genetic testing apparatus for medical purposes for diagnosing exposure to Sars-Cov-2; chromatogram analyzers for medical use; patient monitoring sensors and alarms; chromatographic instruments for medical use; tools for medical diagnostics, namely, medical ultrasound apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, medical instruments for examining women's reproductive organs, medical instruments for use in performing biopsies; chromatographic apparatus for medical use; physical analyzers for medical use, namely, hematology analyzers for medical diagnostic uses, body composition analyzers for medical purposes, skin moisture analyzers for medical purposes, analyzers for the analysis of body fluids; medical diagnostic saliva pads; immunoadsorption columns for medical diagnostic use; chromatographic columns for medical use; apparatus for blood monitoring for medical use; spittoons for medical purposes; all of the foregoing for use in diagnosing or treating Sars-Cov-2 infections |
| Disclaimer with Predetermined Text | "COV-2" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 8, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 8, 2021 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | PharmACT Holding AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | CH |
| Party Name | NOT AVAILABLE |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 01 - Individual |
| Address | DE |
| Party Name | PharmACT Holding AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | CH |
| Party Name | NOT AVAILABLE |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 01 - Individual |
| Address | DE |
| Party Name | PharmACT Holding AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | CH |
| Party Name | NOT AVAILABLE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 01 - Individual |
| Address | DE |
| Event Date | Event Description |
| Wednesday, September 14, 2022 | GENERIC MADRID TRANSACTION SENT TO IB |
| Wednesday, September 14, 2022 | GENERIC MADRID TRANSACTION CREATED |
| Wednesday, August 24, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, May 24, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, May 24, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, February 22, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 22, 2022 | PUBLISHED FOR OPPOSITION |
| Sunday, February 20, 2022 | NOTIFICATION PROCESSED BY IB |
| Wednesday, February 2, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, February 2, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, February 2, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, January 14, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, January 11, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, January 10, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, January 10, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, August 1, 2021 | REFUSAL PROCESSED BY IB |
| Wednesday, July 14, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, July 14, 2021 | REFUSAL PROCESSED BY MPU |
| Tuesday, July 13, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, July 12, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, July 7, 2021 | ASSIGNED TO EXAMINER |
| Monday, June 28, 2021 | ASSIGNED TO EXAMINER |
| Friday, June 18, 2021 | ASSIGNED TO EXAMINER |
| Friday, March 12, 2021 | APPLICATION FILING RECEIPT MAILED |
| Monday, March 8, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, March 4, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |